JWM
TERN

JPL Wealth Management’s Terns Pharmaceuticals TERN Stock Holding History

JPL Wealth Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$53 – 1975
2026
Q1 		$53 Buy
+1
New +$41 ﹤0.01% 1502

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JPL Wealth Management's TERN Position: Q2 2026 in Review

JPL Wealth Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 1 share — an estimated $53 sold.

JPL Wealth Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $53 in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • JPL Wealth Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • JPL Wealth Management sold 1 Terns Pharmaceuticals share in Q2 2026, an estimated $53.
  • JPL Wealth Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • JPL Wealth Management's Terns Pharmaceuticals position peaked at $53 in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.